SentiSense
Ctrl+K
Quick tip: Press
to search stocks
K
KVUE
Kenvue Inc.
$18.39
+0.14 (+0.77%)
Summary
Stories
News
Metrics
Fundamentals
Recent News
Filter:
Showing 11 of 11 articles
Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations - AOL.com
Unknown
•
17 hours ago
•
Positive
Walmart rolling out digital labels nationwide - KVUE
Unknown
•
1 day ago
•
Neutral
Microsoft responds to outages for users across North America on Friday - KVUE
Unknown
•
1 day ago
•
Neutral
Kenvue exec stock grants land as Kimberly-Clark deal drags on - TechStock²
Unknown
•
1 day ago
•
Neutral
McDonald's CEO facing backlash after trying Big Arch burger - KVUE
Unknown
•
2 days ago
•
Negative
Starboard Value Takes Stake in Fluor as Industrial Investment Cycles Reaccelerate
The Motley Fool
•
3 days ago
•
Neutral
KVUE vs. PG: Which Stock Is the Better Value Option? - Yahoo Finance Singapore
Unknown
•
3 days ago
•
Neutral
KVUE vs. PG: Which Stock Is the Better Value Option? - Yahoo Finance
Unknown
•
3 days ago
•
Neutral
Texas primary: Republicans try to knock Gov. Abbott off November ballot; Hinojosa and others vie for Democratic spot - KVUE
Unknown
•
4 days ago
•
Neutral
Weak EBT card security leaves millions in Texas SNAP benefits exposed to theft, $21M already stolen - KVUE
Unknown
•
5 days ago
•
Negative
Millions of dollars in SNAP benefits stolen - KVUE
Unknown
•
5 days ago
•
Positive
Company Profile
Symbol
KVUE
Market Cap
$35.25B
IPO Date
May 4, 2023
CEO
--
Employees
22,000
Sector
--
Industry
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Country
United States
Exchange
--
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
Read MoreSimilar Stocks
EL
The Estee Lauder Companies Inc.
$92.72
-3.29%